ADVANCED DRUG DELIVERY SYSTEMS: NEW DEVELOPMENTS, NEW TECHNOLOGIES - Market Research

ADVANCED DRUG DELIVERY SYSTEMS: NEW DEVELOPMENTS, NEW TECHNOLOGIES
Pub Time: 2003/09
Published by : Business Communications Co., Inc.
Distributed by : Global Information, Inc.
US $ 3850.00 (Hard Copy)
US $ 4428.00 (PDF by E-mail (Single User License))
INTRODUCTION
Drug delivery is an application of biochemical engineering with technologies aimed at the improvement of safety and efficacy, better compliance and life extension of products. Drug delivery can offer a number of significant benefits to patients and physicians, as well as to the pharmaceutical and biotech industries that use the specialized services of drug delivery companies.
STUDY GOALS AND OBJECTIVES
This BCC study provides an overview of the drug delivery market, a segment that is expanding at a very rapid pace. It examines present and future trends in drug delivery technologies. The study also covers market size, market leaders, factors affecting drug delivery and important products.
Basic principles underlying different drug delivery systems are also discussed along with their use over a five-year period from 2003 to 2008. Companies selling these products are highlighted along with the factors affecting markets for these products, and how these markets are likely to change.
BCC's key objective is to present a comprehensive analysis of the current display market and its future direction in drug delivery, with the emphasis on newer techniques and products.
REASONS FOR DOING THE STUDY
The drug delivery market is changing drastically. This is due to the introduction of new techniques and delivery methods. R&D spending coupled with increasing competition, new technologies, the international marketplace and a changing customer base are contributing to the creation of a new kind of drug delivery system market.
This study looks at almost all the systems of drug delivery markets affected by these factors. This is a very complex market, with many technologies combined to provide better delivery systems and thus, giving rise to niche markets with very specialized applications. The use of liposomes and polymers for sustained release oral/injectable drug delivery is a good example.
Inhalation delivery, pegylation, gene therapy and liposomes are emerging and significant new markets. Together, these techniques can be a multibillion-dollar global market in the next few years.
Growth by acquisition and corporate collaboration to develop better delivery systems are also covered in this report, e.g., acquisition of The Liposome Company by Elan. This study discusses the strength and weaknesses of drug development market in light of the new technologies, growing competition and changing customer needs.
CONTRIBUTION OF THE STUDY AND FOR WHOM
The study covers areas of growth and decline from the points of view of manufacturers and users. It presents the types of drug delivery systems and the technologies they involve. Regulations governing their use, technological descriptions and issues, applications, market factors and potential and projected markets for 2003 and 2008 are also studied. This study will be of interest to the pharmaceutical industry, biotechnological companies and research firms working on new drug delivery systems and drug development.
It also makes a contribution by bringing together in one place much of the information on new products and new technologies in drug delivery industry. This study can be a source for many of the estimates relating to consumption of various drug delivery products.
SCOPE OF THE STUDY
This study encompasses the major types of drug delivery systems used in the health industry. BCC analyzes each technology, and looks at the manufacturers, new products, sales estimates, market projections and market share. Technological issues, including the latest trends and developments, are discussed. Also discussed are some of the latest technologies, e.g., gene therapy, resealed erythrocytes, etc. BCC analyzes the industry on a worldwide basis along with government regulations and U.S. Food and Drug Administration (FDA) actions.
METHODOLOGY
Comprehensive literature and patent searches were conducted. The literature included technical newsletters and journals, as well as many other sources. Data was collected through interviews with personnel from various pharmaceutical and biotech companies. This was complied, and projections were based on such estimates as the current number of end users, potential end users, likely unit prices, consumption rates and market trends.
INFORMATION SOURCES
BCC surveyed many companies to obtain data for this study. Included were manufacturers and end users of drug delivery systems. BCC gathered data from these industries and spoke with their officials, consulted newsletters, company literature, product literature, as well as a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were done. In addition, BCC compiled data from current financial and trade information and government sources.